Aviva In-Home Care is honored to be voted 2024’s Best Home Care Agency in San Francisco by The J’s readers!  Our second year in a row for this award.  We appreciate your confidence and trust in what we do!

Our mission is to empower older adults and those managing chronic diseases to maintain independence, joy, and well-being. With nursing oversight, a highly experienced management team, a reliable and trustworthy caregiving team, and technology-forward services, we offer customizable home care for safe aging in place.

If you or a loved one is in need of in-home care services anywhere in the Bay Area, fill out a form on our website today: https://lnkd.in/gA_3ugzU

If you or an aging loved one are considering Companion Care at Home in Atherton, CA, please contact the caring staff at Aviva In-Home Care today at (415) 463-1400

Aviva In-Home Care provides exceptional senior home care in the Bay Area, including San Francisco, Burlingame, San Mateo, Hillsborough, Atherton, Menlo Park, Palo Alto, Berkeley, Lafayette, Orinda, and surrounding areas.

• Author
• Recent Posts

Evan Loevner

CEO at Aviva In-Home Care

As a former hospital administrator, I launched Aviva with the goal of having a more focused, direct impact on the delivery of care than I could ever accomplish within a hospital setting. For me, the joy of running an organization like Aviva In-Home Care is having the ability to positively improve the lives of individuals needing customized care. As a passionate Bay Area resident, I know that many local seniors can benefit from new approaches to in-home care, that will bring them more connection to the community, and provide families with a greater sense of comfort that their loved one is indeed matched with an ideal caregiver.

Latest posts by Evan Loevner (see all)

• Six Strategies for Better Sleep for Your Elderly Loved One - December 17, 2024
• What to Look for in Senior Post-Hospital Care Providers - December 10, 2024
• Protecting Your Loved One From Falls When Visiting Family Over the Holidays - December 3, 2024